Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Consumer Healthcare
Vanwall Road, Maidenhead, Berks, SL6 4UB
Telephone: +44(0)1628 692 002
Fax: +44(0)1628 414 728
Medical Information Direct Line: 0845 111 0151
Medical Information e-mail: carelineuk@pfizer.com
Customer Care direct line: 0845 111 0151
Medical Information Fax: +44(0)1628 414 728

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 17/11/2010
SPC Anadin Extra Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/11/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
  • Change to section 6. 5 - Nature and Contents of Container
Date of revision of text on the SPC:   02-Sep-2010
Legal Category:   P, GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
To add a pack size of 10 tablets and to update the registered details of the drum container, including the container materials (HDPE), technical dimensions and specifications.
Updated on 06/05/2010 and displayed until 17/11/2010
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   27-Apr-2010
Legal Category:   P, GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Change in Marketing Authorisation Holder name and address
Updated on 15/05/2008 and displayed until 06/05/2010
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   18-Apr-2008
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Update of section 4.8  re Hypersensitivity warnings following MHRA letter of 27/09/07
Updated on 12/02/2008 and displayed until 15/05/2008
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.9 - Overdose
  • Change to section 5.2 - Pharmacokinetic Properties
  • Change to section 6.2 - Incompatibilities
Date of revision of text on the SPC:   02/2008
Legal Category:   GSL/P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
To update the SMPC to bring in line with other Wyeth Products containing the same active ingredients
Updated on 06/12/2007 and displayed until 12/02/2008
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
Date of revision of text on the SPC:   11/2007
Legal Category:   GSL/P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
 
 
Increase of shelf life from 24th months to 36 months.
Updated on 22/10/2007 and displayed until 06/12/2007
Reasons for adding or updating:
  • Change to section 3 - Pharmaceutical form
Date of revision of text on the SPC:   07/2006
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
One line got missed out of the description of the pharmaceutical form ie:
 
White, capsule shaped tablet with a break bar on one side, with the letter "A" and "E" debossed on the other.
Updated on 24/07/2006 and displayed until 22/10/2007
Reasons for adding or updating:
  • Change to section 4.9 - Overdose
Date of revision of text on the SPC:   07/2006
Legal Category:   GSL/P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
 
section 4.9 overdose amended to reflect changes to symptoms and management of active substances (Aspirin/Paracetamol/Caffeine)
 
Updated on 22/03/2006 and displayed until 24/07/2006
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 10 (date of (partial) revision of the text
Updated on 17/12/2004 and displayed until 22/03/2006
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
  paracetamol
  caffeine
  acetylsalicylic acid